Oorsprong van het eerstegraads netwerk van Ranya Dajani
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Extinct | Pharmaceuticals: Major | 14 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Ranya Dajani via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CELGENE | Biotechnology | Corporate Officer/Principal | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | General Counsel General Counsel Corporate Officer/Principal | |
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
| NEWELL BRANDS INC. | Industrial Conglomerates | Corporate Officer/Principal | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| EXELON CORPORATION | Electric Utilities | Director/Board Member | |
| ONCOLYTICS BIOTECH INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| SONOMA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ATYR PHARMA, INC. | Pharmaceuticals: Major | General Counsel | |
| ROSETTA GENOMICS LTD. | Biotechnology | Chief Executive Officer | |
Otsuka Pharmaceutical Development & Commercialization, Inc.
 Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | Pharmaceuticals: Major | General Counsel | |
| ONCOSEC MEDICAL INCORPORATED | Medical/Nursing Services | Chief Executive Officer Director/Board Member Director of Finance/CFO General Counsel | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree | |
| Syracuse University | College/University | Undergraduate Degree | |
| Princeton University | College/University | Undergraduate Degree | |
| St. John's University | College/University | Undergraduate Degree | |
| University of Delaware | College/University | Graduate Degree | |
| AVEO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | General Counsel | |
| Universidad Nacional Autónoma de México | College/University | Doctorate Degree | |
Epilepsy Foundation
 Epilepsy Foundation Miscellaneous Commercial ServicesCommercial Services Epilepsy Foundation provides welfare services. It offers therapies to stop seizures, wellness institute and legal issue services. The company was founded in 1967 and is headquartered in Landover, MD. | Miscellaneous Commercial Services | Director/Board Member | |
New Jersey State Bar Association
 New Jersey State Bar Association Miscellaneous Commercial ServicesCommercial Services New Jersey State Bar Association operates as a not-for-profit organization. It educates the public to enhance awareness of the legal system. The company was founded in June 1899 and is headquartered in New Brunswick, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
Kent Place School, Inc.
 Kent Place School, Inc. Other Consumer ServicesConsumer Services Kent Place School, Inc. operates as girl's day school. The school operates preschool, primary school, middle school and upper school. The school was founded in 1894 and is headquartered in Summit, NJ. | Other Consumer Services | Director/Board Member | |
| Instituto Nacional de Salud Pública de México | Corporate Officer/Principal | ||
| Dickinson Law School | College/University | Graduate Degree Graduate Degree | |
Curate Biosciences
 Curate Biosciences Miscellaneous Commercial ServicesCommercial Services Curate Biosciences engages in the development of a liquid biopsy platform for obtaining rare circulating tumor cells. It offers a desktop fluidic system for cell separation that pumps blood through a disposable microchip. The company was founded by Michael D. Grisham in 2002 and is headquartered in Richmond, VA. | Miscellaneous Commercial Services | Director/Board Member | |
| UROGEN PHARMA LTD. | Biotechnology | Director of Finance/CFO | |
Instituto Nacional de Ciencias Medicas y Nutricion
 Instituto Nacional de Ciencias Medicas y Nutricion Hospital/Nursing ManagementHealth Services Instituto Nacional de Ciencias Medicas y Nutricion operates hospitals. The private company is based in Mexico City, Mexico. | Hospital/Nursing Management | Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
| Temple University Beasley School of Law | College/University | Graduate Degree | |
Receptor Life Sciences, Inc.
 Receptor Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Receptor Life Sciences, Inc. operates as a pharmaceutical development company. It offer treatment of pain, central nervous systems, metabolic disorders, and gastrointestinal disorders. The company was founded in 2015 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member | |
Engage Therapeutics, Inc.
 Engage Therapeutics, Inc. BiotechnologyHealth Technology Engage Therapeutics, Inc. engages in the development of rescue therapy for uncontrolled epileptic seizures. The company was founded by Gregory T. Mayes III and Jouko Isojarvi in 2017 and is headquartered in Summit, NJ. | Biotechnology | Founder | |
Antios Therapeutics, Inc.
 Antios Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Antios Therapeutics, Inc. operates as a biopharmaceutical company devoted to developing therapies for viral diseases. The company was founded by Abel De La Rosa, Doug Mayers and Idean Marvasty on October 30, 2018 and is headquartered in Atlanta, GA. | Pharmaceuticals: Major | Chief Executive Officer | |
| ADVAXIS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
| PHATHOM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Wuju Foods LLC | Chairman | ||
Andelyn Biosciences
 Andelyn Biosciences BiotechnologyHealth Technology Andelyn Biosciences is a full-service cell and gene therapy company that specializes in the development, characterization, and production of viral vectors for gene therapy. The private company is based in Columbus, OH. The company operates out of three facilities in Ohio and offers support to its clients in developing curative cell and gene therapies from concept through plasmid development and manufacturing, process development, and cgmp clinical and commercial manufacturing. Andelyn's advanced digital model, quality system, full regulatory support, and supply chain vertical integration help accelerate the development and manufacturing of its clients' innovative cell and gene therapies. The company has more than 20 years of experience and has produced cgmp material for over 450 clinical batches and 75 clinical trials. Andelyn's versatile capabilities include cgmp manufacturing capacity for both adherent and suspension processes up to a 2,000-liter capacity. The CEO of the company is Wade Macedone. | Biotechnology | Chief Executive Officer | |
Reunion Neuroscience, Inc.
 Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada. | Biotechnology | Chief Executive Officer | |
| AYALA PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
| City of Summit (New Jersey) | Municipality | Corporate Officer/Principal | |
Sellas Life Sciences Group Ltd.
 Sellas Life Sciences Group Ltd. Pharmaceuticals: MajorHealth Technology Sellas Life Sciences Group Ltd. manufactures pharmaceutical products. It focuses on innovative products to treat cancer and central nervous system diseases. The firm’s product candidate, licensed from Memorial Sloan-Kettering Cancer Center is a late-stage innovative WT1-targeting synthetic heteroclitic epitope immunotherapeutic in development for hematological malignancies and solid tumors characterized by an overexpression of the WT1 (Wilms Tumor Protein) antigen. The company was founded by Angelos M. Stergiou in 2012 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Statistieken
Internationaal
| Verenigde Staten | 41 |
| Mexico | 4 |
| Canada | 3 |
| Israël | 3 |
| Frankrijk | 2 |
Sectoraal
| Health Technology | 28 |
| Consumer Services | 11 |
| Commercial Services | 6 |
| Health Services | 3 |
| Producer Manufacturing | 2 |
Operationeel
| Director/Board Member | 57 |
| Corporate Officer/Principal | 32 |
| Chief Executive Officer | 20 |
| President | 18 |
| Independent Dir/Board Member | 14 |
Sterkste connecties
| Insiders | |
|---|---|
| Thomas Ridge | 49 |
| Daniel O'Connor | 22 |
| Gregory Mayes | 18 |
| Andres Gutiérrez | 13 |
| Ken Berlin | 11 |
| Mayo Pujols | 11 |
| Molly Henderson | 10 |
| Sara Bonstein | 9 |
| Robert W. Ashworth | 7 |
| Christopher M. Duke | 7 |
| Anthony A. Lombardo | 5 |
| Al Blunt | 3 |
| Thomas W. Hare | 2 |
| Noelle Heber | 1 |
- Beurs
- Insiders
- Ranya Dajani
- Bedrijfsconnecties
